Malignant disease and immunosuppression

Tiotropium – what role in asthma?
Drug and Therapeutics Bulletin Sep 2015, 53 (9) 102-104; DOI: 10.1136/dtb.2015.9.0349
Second-generation long-acting injectable antipsychotic agents: an overview
Drug and Therapeutics Bulletin Sep 2012, 50 (9) 102-105; DOI: 10.1136/dtb.2012.08.0127
Sequential therapy for H. pylori eradication
Drug and Therapeutics Bulletin Sep 2011, 49 (9) 102-105; DOI: 10.1136/dtb.2011.02.0053
Insulin pump therapy
Drug and Therapeutics Bulletin Sep 2012, 50 (9) 105-108; DOI: 10.1136/dtb.2012.09.0130
Back to the future
Drug and Therapeutics Bulletin Oct 2010, 48 (10) 109; DOI: 10.1136/dtb.2010.10.0049
Improving inhaler technique – who needs teaching?
Drug and Therapeutics Bulletin Oct 2012, 50 (10) 109; DOI: 10.1136/dtb.2012.10.0131
The use of ‘specials’ in primary care
Drug and Therapeutics Bulletin Oct 2010, 48 (10) 110-112; DOI: 10.1136/dtb.2010.10.0051
Imiquimod for superficial and in situ skin malignancy
Drug and Therapeutics Bulletin Oct 2009, 47 (10) 113-116; DOI: 10.1136/dtb.2009.09.0040
An update on the drug treatment of neuropathic pain. Part 1: antidepressants
Drug and Therapeutics Bulletin Oct 2012, 50 (10) 114-117; DOI: 10.1136/dtb.2012.10.0133
Do corticosteroids improve outcome in meningitis?
Drug and Therapeutics Bulletin Oct 2010, 48 (10) 116-120; DOI: 10.1136/dtb.2010.10.0050

Main menu